Repeats as part of investigations, ja oder nein? [BE/BA News]

posted by ElMaestro  – Belgium?, 2018-05-22 00:17 (894 d 00:18 ago) – Posting: # 18797
Views: 6,691

Thanks Ohlbe,

» The FDA have just published their revised guideline on bioanalytical method validation.

for this document.

Now a million dollar question:
Are you on basis of the wording on page 13 allowed to do a repeat analysis as part of an investigation? Is for example absent or low IS response (without obvious poor chromatography) itself an assignable cause? If it is, then that would negate the need for an investigation, right?

If taken literally I am inclined to think the guidance does not allow repeats as part of investigations (to me, investigations are done when root causes are not known but potential root causes are being sought).
Common sense takes me a bit in the opposite direction and I would any day prefer to talk about reported repeats and unreported repeats on basis of the presence of a cause.

I could be wrong, but...

Best regards,
ElMaestro

No, of course you do not need to audit your CRO if it was inspected in 1968 by the agency of Crabongostan.

Complete thread:

Activity
 Admin contact
21,180 posts in 4,415 threads, 1,476 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Saturday 23:36 CET (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5